Curative Biotechnology
(OTC) CUBT
Curative Biotechnology Financials at a Glance
Market Cap
$6.66M
Revenue (TTM)
$0.00
Net Income (TTM)
$2.96M
EPS (TTM)
$-0.00
P/E Ratio
-253.09
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.00
Volume
2,057
Open
$0.86
Price
$1.00
Volume
2,057
Open
$0.86
Previous Close
$1.00
Daily Range
$0.81 - $1.00
52-Week Range
$0.03 - $2.23
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.00
Volume
2,057
Open
$0.86
Previous Close
$1.00
Daily Range
$0.81 - $1.00
52-Week Range
$0.03 - $2.23
CUBT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Curative Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
3
CEO
I. Richard Garr
Website
www.curativebiotech.comHeadquarters
Palm Beach Gardens, FL 33410, US
CUBT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
19%
Return on Assets
-61%
Earnings Yield
-0.40%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.66M
Shares Outstanding
6.75M
Volume
2.06K
Short Interest
0.00%
Avg. Volume
1.60K
Financials (TTM)
Gross Profit
$87.84K
Operating Income
$1.50M
EBITDA
$1.41M
Operating Cash Flow
$868.87K
Capital Expenditure
$4.00
Free Cash Flow
$868.87K
Cash & ST Invst.
$45.04K
Total Debt
$1.36M
Curative Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$21.93K
+17.0%
Gross Margin
0.00%
N/A
Market Cap
$6.66M
N/A
Market Cap/Employee
$1.67M
N/A
Employees
4
N/A
Net Income
$482.00K
+46.4%
EBITDA
$260.00K
+61.8%
Quarterly Fundamentals
Net Cash
$2.89M
-36.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$3.11M
+39.0%
Return on Assets
-60.61%
N/A
Return on Invested Capital
19.14%
N/A
Free Cash Flow
$185.27K
-73.6%
Operating Cash Flow
$185.27K
-101.9%